首页> 外文OA文献 >Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

【2h】

Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

机译：在资源有限的环境中艾滋病毒感染的个体中未煮沸的Atazanavir的药物生物学：艾滋病临床试验组（ACTG）珍珠研究（NWCS 342）的副研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jose R. Castillo-Mancilla; Christina L. Aquilante; Michael F. Wempe; Laura M. Smeaton; Cynthia Firnhaber; Alberto M. LaRosa; Nagalingeswaran Kumarasamy; Adriana Andrade; Gautam Baheti; Courtney V. Fletcher; Thomas B. Campbell; David W. Haas; Samantha MaWhinney; Peter L. Anderson;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342) [J] . Castillo-Mancilla Jose R., Aquilante Christina L., Wempe Michael F., The Journal of Antimicrobial Chemotherapy . 2016,第6期

机译：在资源有限的环境中未增强阿扎那韦的药物遗传学研究：艾滋病临床试验小组（ACTG）PEARLS研究的子研究（NWCS 342）
2. Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230 [J] . Kumarasamy Nagalingeswaran, Aga Evgenia, Ribaudo Heather J., Clinical infectious diseases . 2015,第10期

机译：Lopinavir / Ritonavir单药治疗在资源有限的地区作为二线抗逆转录病毒治疗：AIDS临床试验组（ACTG）A5230的第104周分析
3. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes fo [J] . Telzak EE, Chirgwin KD, Nelson ET, The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease . 1999,第4期

机译：HIV感染患者中耐多药结核病的预测指标以及对特定药物疗法的反应。美国国立研究所的特里·贝恩（Terry Beirn）艾滋病临床研究社区计划（CPCRA）和艾滋病临床试验小组（ACTG）
4. PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA(ACTG) [C] . SHEFALI S. VERMA, ALEX T. FRASE, ANURAG VERMA, Pacific Symposium on Biocomputing . 2016

机译：艾滋病临床试验组数据（ACTG）中的苯群相互作用研究（PHEWIS）
5. Reducing the Symptoms of Generalized Anxiety Disorder in Adult Females Utilizing Mindfulness-Based Cognitive Therapy in an Individual Setting: A Clinical Case Study [D] . Mitchell, Lilia Elvir. 2018

机译：在个人环境中利用谨慎的认知治疗，减少成年女性的广义焦虑症的症状：临床案例研究
6. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342) [O] . Jose R. Castillo-Mancilla, Christina L. Aquilante, Michael F. Wempe, -1

机译：在资源有限的环境中未增强阿扎那韦的药物遗传学研究：艾滋病临床试验小组（ACTG）PEARLS研究的子研究（NWCS 342）
7. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 [O] . McComsey, Grace A., Kitch, Douglas, Daar, Eric S., 2011

机译：抗逆转录病毒天真患者的骨矿物质密度和骨折，随机接受阿巴卡韦-拉米夫定或替诺福韦地替莫韦酯富马酸酯-依米他滨与依非韦伦或阿扎那韦-利托那韦的联合治疗：AIDS临床试验组A5224s，是ACTG A5202的一项子研究
8. Studies of Ocular Complications of AIDS (SOCA). Foscarnet- GanciclovirCytomegalovirus Retinitis Trial (FGCRT). AIDS Clinical Trial Group (ACTG) Protocol 129. Antiviral Effects of Foscarnet and Ganciclovir Therapy on HIV p24 Antigen in Patients with AIDS a [R] . 1995

机译：艾滋病眼部并发症（sOCa）的研究。膦甲酸 - 更昔洛韦巨细胞病毒视网膜炎试验（FGCRT）。艾滋病临床试验组（aCTG）议定书129.膦甲酸和更昔洛韦治疗对艾滋病患者HIV p24抗原的抗病毒作用

Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

著录项

引文网络

相似文献

相关主题

期刊订阅